This 1 hour documentary film is from BBC2. The makers say: “The Psychedelic Drug Trial has exclusive access to a ground-breaking new trial at Imperial College London. The trial sees, for the first time ever under controlled conditions, a psychedelic drug tested…
Read more
Rachel Schraer reports for the BBC: “Dr Carhart-Harris said that after psychedelic therapy, participants reported feeling ‘recalibrated, reset like they haven’t for years” and “enjoying life’.” “Psychedelic drug psilocybin, found in magic mushrooms, is as good at reducing symptoms of depression…
Read more
This article has been written (within an American context) by Derek Beres and published on the Big Think website. It begins: “Psychedelic therapy is imminent. Within six years, the market for this new wave of therapeutics is predicted to reach nearly $7 billion . With advocates and…
Read more
“The fact that psilocybin is classified as a Class A drug means there has been a research blackout for nearly 50 years into the beneficial effect it can have in improving the lives of people suffering from PTSD and depression.”Arfon…
Read more
“Scientists are developing psilocybin, the active ingredient in magic mushrooms, into a treatment for depression.” Reporting for Vox, Sigal Samuel writes : “… drugs like traditional antidepressants are, at best, only a partial solution . While their effectiveness has been hotly contested over the past…
Read more
Writing in The Guardian, Jamie Doward reports : “A growing number of soldiers suffering from post-traumatic stress disorder are turning to ‘magic mushrooms’ and LSD to treat their condition. But drug laws make it almost impossible to establish whether they work….
Read more
Can magic mushrooms cure depression? The film’s website says: “Over 4 years, filmmaker Monty Wates was given exclusive access to the first ever medical trial to give psilocybin (the psychoactive ingredient in magic mushrooms) to a group of volunteers suffering…
Read more
Written by James Rucker, Jonathan Iliff and David Nutt, the abstract of this article (2017, Neuropharmacology) says: “The classical psychedelic drugs, including psilocybin, lysergic acid diethylamide and mescaline, were used extensively in psychiatry before they were placed in Schedule I of the…
Read more
This article – Psychedelic drugs should be legally reclassified so that researchers can investigate their therapeutic potential – appeared in the British Medical Journal (May 2015). It was written by Dr. James Rucker (specialist registrar in adult psychiatry). The article summary…
Read more
Dr. Robin Carhart-Harris – head of the Psychedelic Research Group at Imperial College London– has worked for the last few years on the brain effects of LSD, psilocybin (magic mushrooms) and MDMA, conducting some pioneering brain imaging studies of these drugs. Most recently…
Read more